| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 39 | 2024 | 1162 | 4.400 |
Why?
|
| Muscle, Smooth | 25 | 2022 | 931 | 3.150 |
Why?
|
| Spinal Cord Injuries | 8 | 2020 | 929 | 2.050 |
Why?
|
| Neuropilin-2 | 4 | 2022 | 55 | 1.900 |
Why?
|
| Myocytes, Smooth Muscle | 13 | 2024 | 703 | 1.750 |
Why?
|
| Inosine | 3 | 2018 | 129 | 1.610 |
Why?
|
| Muscle Contraction | 9 | 2022 | 1209 | 1.450 |
Why?
|
| Urinary Bladder Neoplasms | 12 | 2022 | 2250 | 1.380 |
Why?
|
| Urothelium | 11 | 2019 | 276 | 1.380 |
Why?
|
| Platelet-Derived Growth Factor | 7 | 2015 | 617 | 1.110 |
Why?
|
| Carcinoma, Transitional Cell | 7 | 2022 | 798 | 1.000 |
Why?
|
| Epidermal Growth Factor | 20 | 2005 | 697 | 0.890 |
Why?
|
| Urinary Bladder Diseases | 4 | 2020 | 167 | 0.860 |
Why?
|
| Urinary Bladder, Overactive | 4 | 2024 | 119 | 0.860 |
Why?
|
| Gastrointestinal Motility | 1 | 2022 | 236 | 0.710 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2017 | 2460 | 0.700 |
Why?
|
| Urinary Bladder Neck Obstruction | 4 | 2017 | 82 | 0.670 |
Why?
|
| Tissue Scaffolds | 7 | 2014 | 951 | 0.640 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2018 | 176 | 0.630 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 22 | 2012 | 1658 | 0.610 |
Why?
|
| Membrane Microdomains | 8 | 2008 | 205 | 0.610 |
Why?
|
| Urology | 1 | 2023 | 411 | 0.600 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2011 | 583 | 0.600 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2017 | 129 | 0.540 |
Why?
|
| Systems Biology | 1 | 2020 | 482 | 0.520 |
Why?
|
| Fibroins | 4 | 2021 | 59 | 0.510 |
Why?
|
| Silk | 5 | 2014 | 93 | 0.490 |
Why?
|
| Host vs Graft Reaction | 1 | 2014 | 13 | 0.490 |
Why?
|
| Cell Separation | 1 | 2020 | 1728 | 0.470 |
Why?
|
| Mucous Membrane | 1 | 2018 | 659 | 0.470 |
Why?
|
| Colon | 1 | 2022 | 1804 | 0.460 |
Why?
|
| Glycoproteins | 4 | 2010 | 2202 | 0.450 |
Why?
|
| Regeneration | 10 | 2021 | 1524 | 0.450 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 808 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2022 | 2848 | 0.440 |
Why?
|
| Actins | 4 | 2013 | 2065 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2017 | 998 | 0.420 |
Why?
|
| Cystitis, Interstitial | 2 | 2024 | 68 | 0.410 |
Why?
|
| Cyclin A1 | 1 | 2012 | 11 | 0.410 |
Why?
|
| Rats | 24 | 2021 | 23847 | 0.400 |
Why?
|
| Biocompatible Materials | 5 | 2014 | 1703 | 0.400 |
Why?
|
| Laminectomy | 1 | 2013 | 226 | 0.400 |
Why?
|
| Transcription Factors | 6 | 2024 | 12174 | 0.390 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1058 | 0.390 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2013 | 642 | 0.380 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2015 | 2911 | 0.380 |
Why?
|
| GATA6 Transcription Factor | 2 | 2010 | 54 | 0.370 |
Why?
|
| Growth Substances | 4 | 2005 | 760 | 0.370 |
Why?
|
| Spinal Cord Compression | 1 | 2013 | 234 | 0.370 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 835 | 0.360 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 5803 | 0.360 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2022 | 2884 | 0.350 |
Why?
|
| Ureter | 3 | 2015 | 370 | 0.340 |
Why?
|
| Animals | 64 | 2022 | 169408 | 0.340 |
Why?
|
| Thrombomodulin | 1 | 2010 | 107 | 0.330 |
Why?
|
| Tissue Engineering | 7 | 2017 | 1893 | 0.330 |
Why?
|
| Signal Transduction | 26 | 2021 | 23652 | 0.330 |
Why?
|
| Chromosome Deletion | 2 | 2010 | 1390 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 534 | 0.310 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2542 | 0.300 |
Why?
|
| Endopeptidases | 1 | 2012 | 764 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 3 | 2024 | 2004 | 0.300 |
Why?
|
| Cell Fractionation | 1 | 2008 | 247 | 0.290 |
Why?
|
| Cell Movement | 5 | 2014 | 5216 | 0.290 |
Why?
|
| Myristic Acid | 1 | 2007 | 49 | 0.290 |
Why?
|
| Transcription Factor AP-1 | 5 | 2014 | 321 | 0.290 |
Why?
|
| Carcinoma | 4 | 2013 | 2340 | 0.290 |
Why?
|
| Cells, Cultured | 22 | 2024 | 19023 | 0.290 |
Why?
|
| Cyclooxygenase 2 | 2 | 2007 | 599 | 0.280 |
Why?
|
| Isometric Contraction | 2 | 2018 | 150 | 0.280 |
Why?
|
| Urodynamics | 4 | 2017 | 349 | 0.280 |
Why?
|
| Disease Models, Animal | 10 | 2017 | 18366 | 0.270 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2009 | 125 | 0.270 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2005 | 692 | 0.260 |
Why?
|
| Keratin-5 | 2 | 2017 | 43 | 0.260 |
Why?
|
| Cholesterol | 5 | 2007 | 2913 | 0.250 |
Why?
|
| rho-Associated Kinases | 4 | 2013 | 285 | 0.250 |
Why?
|
| Telomerase | 1 | 2010 | 753 | 0.250 |
Why?
|
| Mice | 36 | 2022 | 82074 | 0.250 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 778 | 0.240 |
Why?
|
| Caveolae | 1 | 2004 | 54 | 0.240 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2005 | 440 | 0.230 |
Why?
|
| Proteomics | 4 | 2020 | 3913 | 0.230 |
Why?
|
| Cytoskeleton | 2 | 2024 | 1180 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 8200 | 0.230 |
Why?
|
| Prostatic Neoplasms | 17 | 2015 | 11229 | 0.230 |
Why?
|
| Genomics | 1 | 2020 | 5928 | 0.220 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9549 | 0.220 |
Why?
|
| Bladder Exstrophy | 1 | 2005 | 106 | 0.220 |
Why?
|
| Caspases | 2 | 2007 | 881 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2017 | 8664 | 0.210 |
Why?
|
| Cell Survival | 6 | 2020 | 5794 | 0.210 |
Why?
|
| Humans | 89 | 2024 | 768887 | 0.210 |
Why?
|
| Phosphorylation | 12 | 2015 | 8317 | 0.210 |
Why?
|
| Enzyme Inhibitors | 7 | 2005 | 3724 | 0.200 |
Why?
|
| Gene Expression Regulation | 6 | 2013 | 11934 | 0.200 |
Why?
|
| Prostate | 8 | 2008 | 1781 | 0.200 |
Why?
|
| RNA, Messenger | 13 | 2024 | 12809 | 0.200 |
Why?
|
| Carbachol | 1 | 2022 | 223 | 0.200 |
Why?
|
| Synaptotagmin II | 1 | 2021 | 14 | 0.200 |
Why?
|
| Subrenal Capsule Assay | 1 | 2001 | 27 | 0.190 |
Why?
|
| Synaptotagmin I | 1 | 2021 | 33 | 0.190 |
Why?
|
| Stress, Mechanical | 7 | 2005 | 1680 | 0.190 |
Why?
|
| Membrane Proteins | 6 | 2018 | 7885 | 0.190 |
Why?
|
| Caveolin 1 | 3 | 2013 | 255 | 0.180 |
Why?
|
| Prostatic Hyperplasia | 3 | 2003 | 523 | 0.180 |
Why?
|
| Amides | 1 | 2003 | 452 | 0.180 |
Why?
|
| Urinary Tract | 2 | 2015 | 305 | 0.180 |
Why?
|
| Cell Line | 7 | 2017 | 15603 | 0.180 |
Why?
|
| T-Box Domain Proteins | 2 | 2015 | 472 | 0.180 |
Why?
|
| Androgens | 4 | 2007 | 1285 | 0.180 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 1369 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2013 | 4528 | 0.170 |
Why?
|
| Receptors, Androgen | 5 | 2013 | 1091 | 0.170 |
Why?
|
| Botulinum Toxins | 1 | 2021 | 190 | 0.170 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
| Shiga Toxins | 1 | 2018 | 39 | 0.160 |
Why?
|
| Phenotype | 4 | 2020 | 16735 | 0.160 |
Why?
|
| Neoplasm Metastasis | 5 | 2017 | 4926 | 0.160 |
Why?
|
| Ricin | 1 | 2018 | 70 | 0.160 |
Why?
|
| Arsenic | 1 | 2022 | 358 | 0.160 |
Why?
|
| Muscle Relaxation | 2 | 2011 | 138 | 0.150 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2018 | 108 | 0.150 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10486 | 0.150 |
Why?
|
| Tretinoin | 2 | 2011 | 525 | 0.150 |
Why?
|
| Apoptosis | 9 | 2019 | 9528 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2019 | 252 | 0.150 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2021 | 433 | 0.140 |
Why?
|
| Calibration | 1 | 2020 | 823 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 9 | 2013 | 6131 | 0.140 |
Why?
|
| Receptors, Muscarinic | 1 | 2018 | 157 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2022 | 165 | 0.140 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2017 | 50 | 0.140 |
Why?
|
| Xanthines | 1 | 2017 | 121 | 0.140 |
Why?
|
| Cobalt | 1 | 2017 | 148 | 0.140 |
Why?
|
| Cell Line, Tumor | 13 | 2019 | 17174 | 0.140 |
Why?
|
| Neoplasms | 3 | 2023 | 22390 | 0.130 |
Why?
|
| TRPV Cation Channels | 3 | 2015 | 244 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2009 | 4593 | 0.130 |
Why?
|
| Benchmarking | 1 | 2022 | 1058 | 0.130 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3433 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.130 |
Why?
|
| Transfection | 7 | 2013 | 5763 | 0.130 |
Why?
|
| Myosin Light Chains | 2 | 2013 | 122 | 0.130 |
Why?
|
| DNA | 4 | 2005 | 7214 | 0.130 |
Why?
|
| Cell Division | 10 | 2009 | 4478 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2016 | 3518 | 0.130 |
Why?
|
| Stromal Cells | 3 | 2017 | 1337 | 0.130 |
Why?
|
| Synaptophysin | 1 | 2015 | 140 | 0.130 |
Why?
|
| Perfusion | 1 | 2020 | 1402 | 0.120 |
Why?
|
| Chromium | 1 | 2016 | 133 | 0.120 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 407 | 0.120 |
Why?
|
| Intestinal Mucosa | 3 | 2014 | 3047 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 805 | 0.120 |
Why?
|
| Chromosomal Instability | 1 | 2016 | 176 | 0.120 |
Why?
|
| Gene Silencing | 4 | 2015 | 1505 | 0.120 |
Why?
|
| Triazines | 1 | 2017 | 311 | 0.120 |
Why?
|
| Esophagus | 1 | 2021 | 1043 | 0.120 |
Why?
|
| Bombyx | 2 | 2013 | 58 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 2003 | 594 | 0.120 |
Why?
|
| Computational Biology | 2 | 2023 | 3562 | 0.120 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 1251 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 3 | 2004 | 254 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2012 | 2941 | 0.110 |
Why?
|
| Hepatectomy | 2 | 2019 | 588 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2017 | 538 | 0.110 |
Why?
|
| Guided Tissue Regeneration | 1 | 2014 | 88 | 0.110 |
Why?
|
| Epigenomics | 1 | 2020 | 961 | 0.110 |
Why?
|
| Flow Cytometry | 4 | 2020 | 5905 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2010 | 424 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 4064 | 0.110 |
Why?
|
| Urologic Surgical Procedures | 2 | 2013 | 299 | 0.110 |
Why?
|
| Cell Nucleus | 4 | 2008 | 2885 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 4 | 2015 | 2635 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2015 | 278 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 287 | 0.110 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2013 | 38 | 0.110 |
Why?
|
| Mitral Valve | 1 | 2022 | 1475 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2820 | 0.110 |
Why?
|
| Neurofilament Proteins | 1 | 2015 | 337 | 0.110 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2013 | 21 | 0.110 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2013 | 48 | 0.110 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2013 | 42 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2022 | 2892 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2013 | 1165 | 0.100 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 9618 | 0.100 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 4300 | 0.100 |
Why?
|
| Genes, Dominant | 1 | 2015 | 856 | 0.100 |
Why?
|
| Male | 38 | 2021 | 365249 | 0.100 |
Why?
|
| Pyridines | 2 | 2003 | 2896 | 0.100 |
Why?
|
| Kidney | 2 | 2005 | 7057 | 0.100 |
Why?
|
| Neoplasm Transplantation | 3 | 2006 | 2018 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1739 | 0.100 |
Why?
|
| Cell Membrane | 3 | 2007 | 3659 | 0.100 |
Why?
|
| Polymerization | 1 | 2013 | 155 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 3 | 2013 | 875 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 1246 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2012 | 4148 | 0.100 |
Why?
|
| Taxoids | 1 | 2015 | 668 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 269 | 0.100 |
Why?
|
| Urethra | 1 | 2014 | 407 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 4415 | 0.100 |
Why?
|
| Tenascin | 1 | 2011 | 61 | 0.100 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 91 | 0.090 |
Why?
|
| Epithelial Cells | 7 | 2021 | 3701 | 0.090 |
Why?
|
| Triazoles | 1 | 2017 | 904 | 0.090 |
Why?
|
| Neurosecretory Systems | 2 | 2003 | 223 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 257 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1752 | 0.090 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2011 | 62 | 0.090 |
Why?
|
| Cell Shape | 1 | 2012 | 371 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 237 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1608 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 161 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2012 | 430 | 0.090 |
Why?
|
| Wound Healing | 3 | 2018 | 2815 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2013 | 539 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4363 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3554 | 0.090 |
Why?
|
| Disease Progression | 5 | 2019 | 13677 | 0.090 |
Why?
|
| Detergents | 2 | 2008 | 235 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 3613 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 271 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2022 | 14485 | 0.090 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 178 | 0.080 |
Why?
|
| Facial Bones | 1 | 2011 | 209 | 0.080 |
Why?
|
| Lymphedema | 1 | 2016 | 526 | 0.080 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 125 | 0.080 |
Why?
|
| Microtubules | 1 | 2015 | 1062 | 0.080 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2009 | 15 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 6 | 2013 | 5801 | 0.080 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 1667 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2011 | 458 | 0.080 |
Why?
|
| Cell Differentiation | 7 | 2017 | 11684 | 0.080 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 11119 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2009 | 192 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 3621 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2005 | 2631 | 0.080 |
Why?
|
| Species Specificity | 1 | 2013 | 2419 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2665 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2011 | 487 | 0.080 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 381 | 0.080 |
Why?
|
| Solubility | 2 | 2017 | 1087 | 0.080 |
Why?
|
| Calcium Channels | 2 | 2002 | 624 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 1083 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2010 | 755 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1135 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 527 | 0.070 |
Why?
|
| Mitogens | 3 | 2003 | 229 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2012 | 1970 | 0.070 |
Why?
|
| Cyclodextrins | 1 | 2007 | 63 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2013 | 1913 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2017 | 1982 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 714 | 0.070 |
Why?
|
| Muscles | 1 | 2011 | 1582 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 6982 | 0.070 |
Why?
|
| Skull | 1 | 2011 | 830 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3836 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2008 | 3588 | 0.070 |
Why?
|
| Models, Animal | 3 | 2021 | 2123 | 0.060 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2003 | 128 | 0.060 |
Why?
|
| Female | 22 | 2021 | 397464 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2021 | 3811 | 0.060 |
Why?
|
| Interleukin-6 | 3 | 2004 | 3233 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2005 | 184 | 0.060 |
Why?
|
| Phenanthridines | 1 | 2005 | 51 | 0.060 |
Why?
|
| Neuropilin-1 | 1 | 2005 | 90 | 0.060 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2004 | 13 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 2252 | 0.060 |
Why?
|
| Culture Media, Conditioned | 2 | 2005 | 521 | 0.060 |
Why?
|
| Zinc Fingers | 1 | 2007 | 577 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 321 | 0.060 |
Why?
|
| Receptor, PAR-2 | 1 | 2004 | 33 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7609 | 0.060 |
Why?
|
| Binding Sites | 3 | 2009 | 6023 | 0.060 |
Why?
|
| Dihydrotestosterone | 2 | 2002 | 195 | 0.060 |
Why?
|
| Quantum Dots | 1 | 2006 | 168 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2012 | 2674 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2004 | 81 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 3 | 2013 | 2487 | 0.060 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 152 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2003 | 562 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2006 | 1890 | 0.060 |
Why?
|
| DNA Primers | 5 | 2011 | 2827 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 796 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2008 | 2204 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 287 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2011 | 840 | 0.050 |
Why?
|
| Base Sequence | 6 | 2015 | 12430 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 3250 | 0.050 |
Why?
|
| Heparin | 4 | 2001 | 1636 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2005 | 731 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2007 | 1470 | 0.050 |
Why?
|
| Intestines | 1 | 2012 | 1911 | 0.050 |
Why?
|
| Neurofibromin 1 | 1 | 2004 | 190 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 1990 | 985 | 0.050 |
Why?
|
| Hormones | 1 | 2006 | 871 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2003 | 1647 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2004 | 344 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2015 | 294 | 0.050 |
Why?
|
| Peptides | 1 | 2014 | 4353 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 3629 | 0.050 |
Why?
|
| Membrane Lipids | 1 | 2003 | 252 | 0.050 |
Why?
|
| Gingiva | 1 | 2004 | 423 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2431 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2004 | 563 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2011 | 11262 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2022 | 2576 | 0.050 |
Why?
|
| Calcium Signaling | 2 | 2003 | 738 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1891 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 11521 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4356 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2005 | 1687 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2017 | 4178 | 0.040 |
Why?
|
| Receptors, Angiotensin | 1 | 2000 | 141 | 0.040 |
Why?
|
| Stem Cells | 1 | 2013 | 3540 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2003 | 591 | 0.040 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 1999 | 17 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 422 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 2000 | 168 | 0.040 |
Why?
|
| Urethral Obstruction | 1 | 1999 | 56 | 0.040 |
Why?
|
| Blotting, Western | 4 | 2015 | 5035 | 0.040 |
Why?
|
| Endothelium | 1 | 2022 | 768 | 0.040 |
Why?
|
| Sheep | 1 | 2022 | 1451 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 847 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2001 | 475 | 0.040 |
Why?
|
| Trihexosylceramides | 1 | 2018 | 29 | 0.040 |
Why?
|
| Periodicity | 1 | 2000 | 348 | 0.040 |
Why?
|
| Software | 2 | 2024 | 4480 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 22381 | 0.040 |
Why?
|
| Research Personnel | 1 | 2024 | 590 | 0.040 |
Why?
|
| Genes, erbB-1 | 1 | 1999 | 163 | 0.040 |
Why?
|
| Protein Transport | 2 | 2018 | 1956 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 2018 | 73 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2018 | 3076 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2015 | 368 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 6232 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2005 | 1207 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 18065 | 0.040 |
Why?
|
| Ureteral Obstruction | 1 | 2000 | 297 | 0.040 |
Why?
|
| Glycolipids | 1 | 2018 | 205 | 0.040 |
Why?
|
| France | 1 | 2019 | 497 | 0.040 |
Why?
|
| Models, Biological | 3 | 2012 | 9499 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2002 | 1494 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2018 | 4291 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2019 | 408 | 0.040 |
Why?
|
| Mutagenicity Tests | 1 | 2017 | 46 | 0.040 |
Why?
|
| Tumor Microenvironment | 3 | 2017 | 3951 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2003 | 1153 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2414 | 0.040 |
Why?
|
| Gene Expression | 4 | 2003 | 7602 | 0.040 |
Why?
|
| Leucovorin | 1 | 2019 | 643 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2005 | 1266 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 17629 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 407 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1999 | 674 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 755 | 0.030 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 299 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2005 | 3138 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2015 | 1154 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13699 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2017 | 114 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 2395 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2017 | 140 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2016 | 220 | 0.030 |
Why?
|
| Lymphokines | 1 | 1999 | 927 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 385 | 0.030 |
Why?
|
| Extracellular Space | 1 | 1998 | 566 | 0.030 |
Why?
|
| Urine | 1 | 2017 | 362 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3811 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 6856 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2003 | 2858 | 0.030 |
Why?
|
| Endosomes | 1 | 2018 | 525 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 6401 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1101 | 0.030 |
Why?
|
| Proteome | 1 | 2005 | 1891 | 0.030 |
Why?
|
| Epothilones | 1 | 2015 | 42 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1564 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8765 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 647 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 2015 | 99 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2634 | 0.030 |
Why?
|
| Lovastatin | 1 | 2015 | 115 | 0.030 |
Why?
|
| Phylogeny | 1 | 2022 | 2843 | 0.030 |
Why?
|
| Receptors, Prostaglandin | 1 | 2014 | 53 | 0.030 |
Why?
|
| Mutation | 3 | 2015 | 30266 | 0.030 |
Why?
|
| Japan | 1 | 2019 | 1418 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 718 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 1999 | 1714 | 0.030 |
Why?
|
| Survival Rate | 2 | 2013 | 12873 | 0.030 |
Why?
|
| Receptors, Purinergic | 1 | 2014 | 66 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1356 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 1009 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10778 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2019 | 1655 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1620 | 0.030 |
Why?
|
| gamma-Synuclein | 1 | 2013 | 9 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3631 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 59738 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 921 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2016 | 773 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 874 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 1039 | 0.030 |
Why?
|
| Receptor, erbB-2 | 2 | 2000 | 2606 | 0.030 |
Why?
|
| Urinary Calculi | 1 | 2013 | 90 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 4919 | 0.030 |
Why?
|
| Protein Precursors | 3 | 2005 | 1135 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 356 | 0.020 |
Why?
|
| Time Factors | 4 | 2010 | 40266 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 945 | 0.020 |
Why?
|
| Spinal Stenosis | 1 | 2014 | 261 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2016 | 1110 | 0.020 |
Why?
|
| Hip Prosthesis | 1 | 2017 | 924 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1176 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 6512 | 0.020 |
Why?
|
| Rats, Zucker | 2 | 2000 | 131 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 725 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 369 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 9564 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 558 | 0.020 |
Why?
|
| Myocardium | 1 | 2003 | 4790 | 0.020 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 148 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 348 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6805 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 771 | 0.020 |
Why?
|
| Cell Communication | 1 | 2017 | 1660 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 221 | 0.020 |
Why?
|
| DiGeorge Syndrome | 1 | 2011 | 187 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 1047 | 0.020 |
Why?
|
| Calcium | 2 | 2003 | 5792 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2010 | 408 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3591 | 0.020 |
Why?
|
| Blister | 1 | 2009 | 88 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2085 | 0.020 |
Why?
|
| Middle Aged | 7 | 2021 | 223740 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 701 | 0.020 |
Why?
|
| DNA Replication | 1 | 1996 | 1428 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 320 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2002 | 1705 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12252 | 0.020 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2008 | 147 | 0.020 |
Why?
|
| Rabbits | 1 | 2014 | 4774 | 0.020 |
Why?
|
| Palmitic Acid | 1 | 2008 | 149 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 4545 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2909 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2011 | 747 | 0.020 |
Why?
|
| Reactive Oxygen Species | 2 | 2005 | 2149 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 1135 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 2565 | 0.020 |
Why?
|
| Aged | 6 | 2019 | 171790 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2003 | 2695 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2472 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 9081 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 283 | 0.020 |
Why?
|
| Inflammation | 2 | 2016 | 10869 | 0.020 |
Why?
|
| Benzophenanthridines | 1 | 2005 | 27 | 0.020 |
Why?
|
| Ovary | 1 | 1990 | 965 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 1904 | 0.020 |
Why?
|
| Adult | 6 | 2021 | 223818 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20244 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2005 | 26394 | 0.010 |
Why?
|
| Metformin | 1 | 2012 | 909 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 2005 | 395 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4784 | 0.010 |
Why?
|
| Filipin | 1 | 2003 | 14 | 0.010 |
Why?
|
| Octoxynol | 1 | 2003 | 76 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 432 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2019 | 81892 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 14199 | 0.010 |
Why?
|
| Alkaloids | 1 | 2005 | 192 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2003 | 89 | 0.010 |
Why?
|
| Oncogenes | 1 | 2009 | 1236 | 0.010 |
Why?
|
| Swine | 1 | 2013 | 5998 | 0.010 |
Why?
|
| Exocrine Glands | 1 | 2002 | 46 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2525 | 0.010 |
Why?
|
| Histones | 1 | 2013 | 2603 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2003 | 367 | 0.010 |
Why?
|
| Simvastatin | 1 | 2005 | 346 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 626 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 183 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2003 | 380 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2003 | 224 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 664 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2094 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 265 | 0.010 |
Why?
|
| Organ Size | 1 | 2006 | 2268 | 0.010 |
Why?
|
| Endocytosis | 1 | 2005 | 959 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 1222 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2001 | 115 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2862 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2000 | 61 | 0.010 |
Why?
|
| Age Distribution | 1 | 2006 | 2875 | 0.010 |
Why?
|
| Leucine | 1 | 2002 | 548 | 0.010 |
Why?
|
| RNA Interference | 1 | 2009 | 2835 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3775 | 0.010 |
Why?
|
| Leucyl Aminopeptidase | 1 | 2000 | 12 | 0.010 |
Why?
|
| Sex Factors | 1 | 2014 | 10641 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2896 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1328 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2000 | 153 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2000 | 144 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 240 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2000 | 314 | 0.010 |
Why?
|
| Prognosis | 2 | 2013 | 30044 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 3714 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2067 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 36541 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12798 | 0.010 |
Why?
|
| Antibodies | 1 | 2007 | 2422 | 0.010 |
Why?
|
| Receptor, erbB-3 | 1 | 1999 | 143 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2004 | 1395 | 0.010 |
Why?
|
| Curcumin | 1 | 1999 | 97 | 0.010 |
Why?
|
| Keratins | 1 | 2000 | 502 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 751 | 0.010 |
Why?
|
| Protective Agents | 1 | 1999 | 150 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11886 | 0.010 |
Why?
|
| Anilides | 1 | 2001 | 414 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1999 | 750 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1999 | 517 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 972 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8559 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2000 | 844 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1997 | 109 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3608 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 826 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 1625 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1769 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2709 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14795 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1997 | 253 | 0.010 |
Why?
|
| DNA Probes | 1 | 1997 | 543 | 0.010 |
Why?
|
| Zebrafish | 1 | 2007 | 3037 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1997 | 525 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 1169 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 9344 | 0.010 |
Why?
|
| Nitriles | 1 | 2001 | 990 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1553 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 864 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9442 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2000 | 1064 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 2937 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1998 | 1505 | 0.010 |
Why?
|
| Clone Cells | 1 | 1997 | 1670 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 1539 | 0.010 |
Why?
|
| Tyrosine | 1 | 1997 | 1427 | 0.010 |
Why?
|
| Ligands | 1 | 1999 | 3283 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2001 | 1421 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 5707 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1493 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 2916 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2433 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13427 | 0.010 |
Why?
|
| Child | 2 | 2015 | 80969 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41800 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 16051 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3744 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 22294 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1990 | 39394 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21187 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74971 | 0.000 |
Why?
|
| RNA | 1 | 1997 | 2727 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 65485 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1999 | 42684 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1997 | 3839 | 0.000 |
Why?
|